ΜΗ ΑΛΚΟΟΛΙΚΗ ΛΙΠΩΔΗΣ ΝΟΣΟΣ ΤΟΥ ΗΠΑΤΟΣ
Παραπομπές
1. Yki-Järvinen H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol. 2014 Nov;2(11):901-10. doi: 10.1016/S2213-8587(14)70032-4. Epub 2014 Apr 7. PMID: 24731669.
https://pubmed.ncbi.nlm.nih.gov/24731669/
2. Del Ben M, Polimeni L, Baratta F, Pastori D, Loffredo L, Angelico F. Modern approach to the clinical management of non-alcoholic fatty liver disease. World J Gastroenterol. 2014 Jul 14;20(26):8341-50. doi: 10.3748/wjg.v20.i26.8341. PMID: 25024593; PMCID: PMC4093688.
https://pubmed.ncbi.nlm.nih.gov/25024593
3. Paradis V, Bedossa P. Definition and natural history of metabolic steatosis: histology and cellular aspects. Diabetes Metab. 2008 Dec;34(6 Pt 2):638-42. doi: 10.1016/S1262-3636(08)74598-1. PMID: 19195624.
https://pubmed.ncbi.nlm.nih.gov/19195624/
4. Carr RM, Oranu A, Khungar V. Nonalcoholic Fatty Liver Disease: Pathophysiology and Management. Gastroenterol Clin North Am. 2016 Dec;45(4):639-652. doi: 10.1016/j.gtc.2016.07.003. Epub 2016 Oct 13. PMID: 27837778; PMCID: PMC5127277.
https://pubmed.ncbi.nlm.nih.gov/27837778/
5. Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, Swain MG, Congly SE, Kaplan GG, Shaheen AA. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022 Sep;7(9):851-861. doi: 10.1016/S2468-1253(22)00165-0. Epub 2022 Jul 5. PMID: 35798021.
https://pubmed.ncbi.nlm.nih.gov/35798021/
6. - - -
1. Yki-Järvinen H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol. 2014 Nov;2(11):901-10. doi: 10.1016/S2213-8587(14)70032-4. Epub 2014 Apr 7. PMID: 24731669.
https://pubmed.ncbi.nlm.nih.gov/24731669/
2. Del Ben M, Polimeni L, Baratta F, Pastori D, Loffredo L, Angelico F. Modern approach to the clinical management of non-alcoholic fatty liver disease. World J Gastroenterol. 2014 Jul 14;20(26):8341-50. doi: 10.3748/wjg.v20.i26.8341. PMID: 25024593; PMCID: PMC4093688.
https://pubmed.ncbi.nlm.nih.gov/25024593
3. Paradis V, Bedossa P. Definition and natural history of metabolic steatosis: histology and cellular aspects. Diabetes Metab. 2008 Dec;34(6 Pt 2):638-42. doi: 10.1016/S1262-3636(08)74598-1. PMID: 19195624.
https://pubmed.ncbi.nlm.nih.gov/19195624/
4. Carr RM, Oranu A, Khungar V. Nonalcoholic Fatty Liver Disease: Pathophysiology and Management. Gastroenterol Clin North Am. 2016 Dec;45(4):639-652. doi: 10.1016/j.gtc.2016.07.003. Epub 2016 Oct 13. PMID: 27837778; PMCID: PMC5127277.
https://pubmed.ncbi.nlm.nih.gov/27837778/
5. Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, Swain MG, Congly SE, Kaplan GG, Shaheen AA. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022 Sep;7(9):851-861. doi: 10.1016/S2468-1253(22)00165-0. Epub 2022 Jul 5. PMID: 35798021.
https://pubmed.ncbi.nlm.nih.gov/35798021/
6. - - -
